today show semaglutide Weight loss drugs help change stigmas around obesity STEP UP: Higher Semaglutide Doses

Four of these patients (57.1%) experienced at least one AKI episode, and all four experienced recurrent episodes

Third, pinch the skin gently and insert the needle at a 90-degree angle in one smooth motion rather than slowly pushing through the skin

ICH Harmonised Tripartite Guideline

The SELECT trial, published in The Lancet (October 22, 2025), provides a landmark analysis confirming that the cardioprotective benefits of semaglutide extend beyond weight loss alone. The SELECT Trial: Study Overview The SELECT trial (NCT03574597) enrolled 17,604 participants aged 45 years and above across 41 countries and 804 sites

Kakutani-Hatayama M et al